Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-28

FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for memantine hydrochloride, a generic form of memantine used to treat Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)

Snippet

SUPPL AP for MEMANTINE HYDROCHLORIDE (MEMANTINE HYDROCHLORIDE)